Srinivasan Rajendran & Rahul Dutta

Co-Founders

The life sciences and medical device consulting industry is rapidly evolving toward a Total Lifecycle Excellence model, driven by the need for faster innovation, predictable regulatory approvals, and seamless global market access. In India, the focus has shifted from cost-driven manufacturing to innovation-led research and development, supported by regulatory reforms, the Ayushman Bharat Digital Mission, and the growing digital health ecosystem. Globally, the rise of Software as a Medical Device (SaMD), AI-enabled diagnostics, IoMT, and data-driven healthcare solutions is redefining how products are designed, validated, and monitored post-market.

Despite these advancements, MedTech and digital health companies face significant challenges. Increasing regulatory complexity across CDSCO, US FDA, EU MDR/IVDR, and global cybersecurity and data privacy expectations often delay market entry. Startups and growth-stage companies particularly struggle to transition from proof-of-concept to market-ready products due to fragmented regulatory planning and limited inhouse expertise.

Amid these challenges, D2R Global Consulting stands out as a comprehensive Design-to-Regulatory advisory partner for MedTech, IVD, diagnostics, biotech, and digital health companies. Unlike conventional consulting models focused solely on documentation, D2R integrates design, development, regulatory, clinical, and quality requirements into a single execution framework. This end-to-end approach enables faster approvals, reduced compliance risk, and sustainable global scalability.

A Redefining Journey

D2R began its journey in 2018 as Elite QARA Consulting, with a sharp focus on quality and regulatory advisory services for medical device companies. As client needs evolved, the firm rebranded as D2R Global Consultingshort for “Design to Regulatory”-to reflect its expanded capability of supporting products from early concept and prototyping through regulatory approval and commercialization.

Over time, D2R evolved into a turnkey lifecycle partner, expanding its expertise across regulatory strategy, clinical evidence generation, quality management systems, and post-market compliance. This evolution enabled deeper, long-term partnerships with innovators across global markets.

Today, D2R has supported over 275 clients, delivered more than 200 projects, and enabled 125+ regulatory approvals across India, the United States, Europe, GCC, Israel, and South Africa. As an Authorized Representative (AR), the firm continues to support global market access for emerging and established MedTech companies.

“By transforming ideas into global market-ready solutions, we accelerate MedTech innovation with precision, compliance, and expertise,” states Srinivasan Rajendran, Co-Founder, D2R Global Consulting.

Carving a Niche for MedTech Success

D2R positions itself as an end-to-end partner across the medical device and digital health lifecycle. Regulatory consulting remains a core strength, with expertise in CDSCO licensing, US FDA pathways including 510(k), De Novo, and IDE, as well as CE certification under EU MDR and IVDR frameworks.

The firm also supports quality excellence through ISO 13485:2016 implementation, risk management systems, MDSAP readiness, and post-market surveillance. Clinical services include pilot and pivotal study support, clinical evaluation reports, and performance evidence generation aligned with global regulatory expectations.

Driving Digital Health & AI Innovation

D2R plays a pivotal role in enabling next-generation digital health and AI-driven medical technologies. The firm supports SaMD, Clinical Decision Support software, and AI/ ML-enabled solutions with regulatory strategy, validation, interoperability standards such as HL7 and PACS, and cybersecurity and data privacy compliance including HIPAA, GDPR, and India’s DPDPA.

A Robust Future Roadmap

Looking ahead, D2R Global Consulting is focused on expanding capabilities in digital diagnostics, digital therapeutics, AI/ML compliance, and cybersecurity assurance. The firm aims to strengthen India market-entry support, global expansion strategies, and investor-aligned regulatory readiness, enabling innovators to transition seamlessly from regulatory approval to commercial success.